ClassID:

169357

G01N33/9433 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors; Neurotransmitters (Nor)adrenaline

Recent Application in this class:
#1
20260148848
2026-05-28

BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF

#2
20260002951
2026-01-01

METHOD FOR PROVIDING INFORMATION FOR BRAIN DOPING DIAGNOSIS

#3
20220196682
2022-06-23

CATECHOLAMINE CONCENTRATIONS IN A BLOOD SAMPLE AND ARTERIAL HYPERTENSION STATUS IN A SUBJECT FOR A DIFFERENTIAL DIAGNOSIS OF NEURODEGENERATIVE DISEASES INCLUDING ALZHEIMER'S DISEASE

#4
20220023627
2022-01-27

Methods for assessing efficacy of renal neuromodulation and associated systems and devices

#5
20210293831
2021-09-23

Method of Performing Differential Diagnosis of Neurodegenerative Diseases in a Subject

#6
20210249131
2021-08-12

Method of Performing Differential Diagnosis of Neurodegenerative Diseases in a Subject

#7
20210072155
2021-03-11

Methods for quantifying ligand efficacy in G-protein coupled receptors using single-molecule fluorescence energy transfer

#8
20190277867
2019-09-12

Application of artificially expressed HSP27 protein in detecting a residue of a β2-adrenergic receptor agonist-based drug

#9
20180355037
2018-12-13

Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment

#10
20180143213
2018-05-24

METHODS FOR THE DETECTION OF ANTIBODIES AGAINST MEMBERS OF THE CARDIAC RECEPTOR FAMILY

#11
20170347954
2017-12-07

Methods for assessing efficacy of renal neuromodulation and associated systems and devices

#12
20150355204
2015-12-10

MARKER FOR DEPRESSION, ASSAY METHOD, METHOD FOR DETERMINING DEPRESSION, SCREENING METHOD FOR ANTIDEPRESSANTS, AND KIT

#13
20140249363
2014-09-04

Method for evaluating human blastocyst by norepinephrine level in blastocyst culture solution

#14
20140235864
2014-08-21

Biphenyl derivatives

#15
20130217036
2013-08-22

Diagnostic tools for charcot-marie-tooth disease

#16
20120178757
2012-07-12

Method For The Prevention Of Cancer Metastasis

#17
20110312994
2011-12-22

Biphenyl derivatives

#18
20110201553
2011-08-18

Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength

#19
20100055665
2010-03-04

Luminescence assay using macrocyclic lanthanide (III) complexes

#20
20090156530
2009-06-18

Norepinepherine Transporter Mutants and Uses Thereof

#21
20080026399
2008-01-31

Method of treating bladder and lower urinary tract syndromes

#22
20080015220
2008-01-17

Biphenyl derivatives

#23
20070276003
2007-11-29

Biphenyl derivatives

#24
20070208176
2007-09-06

Biphenyl derivatives

#25
20070199084
2007-08-23

Ubiquitination of Membrane Transporters

#26
20070088054
2007-04-19

Biphenyl derivatives

#27
20070037984
2007-02-15

Biphenyl derivatives

#28
20060229334
2006-10-12

Biphenyl derivatives

#29
20060223860
2006-10-05

Biphenyl derivatives

#30
20060223859
2006-10-05

Biphenyl derivatives

#31
20060223858
2006-10-05

Biphenyl derivatives

#32
20060154307
2006-07-13

Receptor assay

#33
20050019841
2005-01-27

Modulation of signaling pathways